Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2020 Apr 22.

Published in final edited form as: J Virol Methods. 2018 Jun 30;260:26–33. doi: 10.1016/j.jviromet.2018.06.018

Table 3.

Agreement between laboratories for each kit using Panel 1.

Kit	Lab Agreement N (%)			Fleiss’ kappa statistic (95% CI)
Kit	All three agreed	Two agreed	No agreement	Fleiss’ kappa statistic (95% CI)
InBios	198 (68.5)	86 (29.8)	5 (1.7)	0.62 (0.57, 0.68)
NovaTec	275 (95.2)	11 (3.8)	3 (1.0)	0.91 (0.85, 0.97)
Euroimmun IgM	260 (90.0)	23 (8.0)	6 (2.1)	0.78 (0.72, 0.84)
Euroimmun IgG	270 (93.4)	16 (5.5)	3 (1.0)	0.89 (0.83, 0.95)
Euroimmun IgM & IgG	271 (93.8)	18 (6.2)	0 (0.0)	0.91 (0.85, 0.98)